Trinity Biosystems Appoints Helen S. Kim to its Board of Directors
Menlo Park, CA - August 6th, 2009 - Trinity Biosystems, a privately held biotechnology company that designs orally delivered bio-therapeutic macromolecules, today announced that it has appointed Helen S. Kim to the company's board of directors.
Most recently, Ms. Kim served as Director and Chief Executive Officer of privately held TRF Pharma, Inc. Previously, she was the Chief Executive Officer and President of Kosan Biosciences Incorporated where she restructured and repositioned the company prior to successfully selling it to Bristol-Myers Squibb in 2008. Ms. Kim's additional industry experience includes senior positions at Affymax, Onyx Pharmaceuticals, Protein Design Labs and Chiron Corporation. In addition to her industry experience, Ms. Kim also served as Chief Program Officer for the Gordon and Betty Moore Foundation from 2003 to 2008. Ms. Kim received a B.S. in Chemical Engineering from Northwestern University and a M.B.A. from the University of Chicago.
"Helen joins Trinity's board of directors at an important stage in the company's development as we continue to progress toward validating our technology platform for the oral delivery of bio-therapeutic macromolecules that represent therapeutically and commercially attractive product opportunities," said M. Amin Khan, PhD, Trinity's president, chief scientific officer and director. "Helen's broad industry experience will help to guide Trinity toward the successful implementation of our technology, product development and partnering strategies and advancement of our pipeline toward value-creating events. Trinity's board of directors and management team join me in welcoming her to our company."
About Trinity
Trinity Biosystems is a pure-play biotechnology company that designs orally delivered bio-therapeutics for endocrine and other disorders. The company's TriPex™ system utilizes a specific and efficient natural biological transport mechanism that is being applied to Trinity's proprietary and partnered programs. Trinity is based in Menlo Park, CA. For more information, please visit www.trinitybiosystems.com.
Contact:
M. Amin Khan, PhD
President and Chief Scientific Officer
Trinity Biosystems, Inc
(650) 566-0780
amin@trinitybiosystems.com
return to top »
| 
